| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/22/2004 | CA2490818A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | CA2489203A1 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/22/2004 | CA2489084A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382605A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands |
| 01/21/2004 | EP1382598A1 Novel heterocyclic derivatives |
| 01/21/2004 | EP1382347A1 Use of CCN protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux |
| 01/21/2004 | EP1382340A1 Therapeutic uses of dehydroepiandrosterone for treating diminished libido and osteoporosis |
| 01/21/2004 | EP1382339A1 Compositions containing pyrrolo [2,3-d] pyrimidine derivatives |
| 01/21/2004 | EP1382337A1 Novel formulation containing paroxetine |
| 01/21/2004 | EP1382334A1 Use of angiotensin II AT1-receptor blockers (ARB), alone or combined with thiazide or angiotensin II for the treatment of stroke |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381627A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381615A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- 1,4]DIOXINO 2,3-e]INDOLE |
| 01/21/2004 | EP1381614A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-f]QUINOXALINE |
| 01/21/2004 | EP1381613A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- 1,4]-benzodioxans |
| 01/21/2004 | EP1381612A1 Antidepressant aza-heterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline |
| 01/21/2004 | EP1381607A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/21/2004 | EP1381606A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/21/2004 | EP1381604A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 01/21/2004 | EP1381603A2 Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands ) |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381600A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381455A1 Stable aqueous colloidal dispersion, method for preparing same |
| 01/21/2004 | EP1381432A2 Hsa-free formulations of interferon-beta |
| 01/21/2004 | EP1381408A2 Modular infusion device and method |
| 01/21/2004 | EP1381373A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method |
| 01/21/2004 | EP1381371A2 Hormone replacement therapy |
| 01/21/2004 | EP1381367A1 Aripiprazole oral solution |
| 01/21/2004 | EP1381365A1 Pyrrolidine sulfonamides |
| 01/21/2004 | EP1381363A1 Imidazo [1,2-a]-pyridine derivatives as mglur5 antagonists |
| 01/21/2004 | EP1381356A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 01/21/2004 | EP1381352A1 Transdermal patch for administering fentanyl |
| 01/21/2004 | EP1280799B1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/21/2004 | EP1242415B1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 01/21/2004 | EP1150660B1 Pharmaceutical effervescent formulation containing metamizol |
| 01/21/2004 | EP1128826B1 Chromone enteric release formulation |
| 01/21/2004 | EP1126852B1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 01/21/2004 | EP0999846B1 Phosphatidic acid-based immune modulator composition |
| 01/21/2004 | EP0977596B1 Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells |
| 01/21/2004 | EP0942723B1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 01/21/2004 | EP0935463B1 Use of anti-neurogenic inflammatory compounds and compositions |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | EP0759772B1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 01/21/2004 | CN1469879A Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469873A Piperidine compounds as anti-allergic |
| 01/21/2004 | CN1469872A A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 01/21/2004 | CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication |
| 01/21/2004 | CN1469863A Crystal form of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl] piperazine hydrochloride |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1469754A Orally administered peptides to ameliorate a therosclerosis |
| 01/21/2004 | CN1469752A Method for treating the central nervous system by administration of IGF structural analogs |
| 01/21/2004 | CN1469746A A retroviral immunotherapy |
| 01/21/2004 | CN1469745A Preventives and remedies for complications of diabetes |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/21/2004 | CN1469735A Liposomal formulation of mitoxantrone |
| 01/21/2004 | CN1468854A Prepn process and use of substituted pyrazole compound |
| 01/21/2004 | CN1468612A Application of cnidium oil in preparing medicine for treating cerebral thrombus and headache |
| 01/21/2004 | CN1468606A Smoking-quiting gettama cigarette |
| 01/21/2004 | CN1135232C Piperazino derivatives as neurokinin antafonists |
| 01/21/2004 | CN1135228C N-aryloxyethyl-indoly-alkylamines for treatment of depression |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680333 Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2004 | US6680330 Rapamycin dialdehydes |
| 01/20/2004 | US6680328 Cholinergic ligands of nicotinic acetyl choline receptors for treatment of central nervous system disorders, smooth muscle contraction disorders, endocrine diseases/disorders, neurodegeneration, inflammation, pain, and drug withdrawal |
| 01/20/2004 | US6680327 Crystalline form VII of cabergoline |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680318 Piperazinomethylbenzamides as delta-opioid receptor agonists |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/20/2004 | US6680314 Azacyclooctane and heptane derivatives, their preparation and use in therapy |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680173 Diagnosis of tauopathies |
| 01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
| 01/20/2004 | US6680169 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 01/20/2004 | US6680072 Producing small, rapidly disintegrating masked tablets; st. john's wort |
| 01/20/2004 | US6679824 Products and methods for brachytherapy |
| 01/20/2004 | CA2308745C 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]hydrohalogenides |
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/20/2004 | CA2273181C 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
| 01/20/2004 | CA2157323C Gepirone dosage form |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2140254C Controlled release morphine preparation |
| 01/15/2004 | WO2004005510A1 NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF |
| 01/15/2004 | WO2004005336A2 β-SHEET BREAKING PEPTIDES |
| 01/15/2004 | WO2004005314A1 ESTRIENO[3,2-b]/[3,4-c]PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS |
| 01/15/2004 | WO2004005299A1 Polymorphic forms of a 4h-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivative |
| 01/15/2004 | WO2004005295A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | WO2004005294A2 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 01/15/2004 | WO2004005293A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |